Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Common Equity (2016 - 2025)

U S Physical Therapy's Common Equity history spans 12 years, with the latest figure at $493.5 million for Q3 2023.

  • For Q3 2023, Common Equity rose 54.9% year-over-year to $493.5 million; the TTM value through Sep 2023 reached $493.5 million, up 54.9%, while the annual FY2022 figure was $317.1 million, 6.69% up from the prior year.
  • Common Equity for Q3 2023 was $493.5 million at U S Physical Therapy, up from $490.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $493.5 million in Q3 2023 and bottomed at $221.2 million in Q1 2019.
  • The 5-year median for Common Equity is $284.8 million (2021), against an average of $298.6 million.
  • The largest YoY upside for Common Equity was 58.61% in 2023 against a maximum downside of 5.71% in 2023.
  • A 5-year view of Common Equity shows it stood at $241.7 million in 2019, then rose by 14.87% to $277.6 million in 2020, then increased by 7.04% to $297.2 million in 2021, then grew by 6.69% to $317.1 million in 2022, then soared by 55.65% to $493.5 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Common Equity are $493.5 million (Q3 2023), $490.0 million (Q2 2023), and $319.5 million (Q1 2023).